Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "coronary-artery-bypass"

5 News Found

CARE Hospitals strengthens advanced cardiac care
Hospitals | June 03, 2026

CARE Hospitals strengthens advanced cardiac care

The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries

Kauvery Hospital sets new benchmark in high-risk cardiac care
Hospitals | April 04, 2026

Kauvery Hospital sets new benchmark in high-risk cardiac care

71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day

Bengaluru docs perform world’s first single-stage robotic heart bypass & prostate cancer surgery
News | January 24, 2026

Bengaluru docs perform world’s first single-stage robotic heart bypass & prostate cancer surgery

World First: Heart bypass without opening the chest achieved by NIH and Emory Team
R&D | January 09, 2026

World First: Heart bypass without opening the chest achieved by NIH and Emory Team

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
Startup | April 28, 2022

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

Cysoni is a bionic device that paces the heart with real-time respiratory modulation

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Global clinical trials are shifting east. Is India ready to lead?

Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America

Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
Rising pharma demand driving our India market strategy: Sanjeev Kumar Khandelwal, Head of Division, Characterization Division, Anton Paar India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International

Packaging